Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practiceMarta Álvarez, Luis Miguel Garcia Sousa, Paz Casas et al.|Journal of Antimicrobial Chemotherapy|2019Cited by 22
Clinical experience with integrase inhibitors in HIV-2-infected individuals in SpainSilvia Requena, Carmen Raya, Iciar Rodríguez-Avial et al.|Journal of Antimicrobial Chemotherapy|2019Cited by 20
The algorithm used for the interpretation of doravirine transmitted drug resistance strongly influences clinical practice and guideline recommendationsCarlos Enrique Guerrero-Beltrán, Javier Martínez‐Sanz, Marta Álvarez et al.|Journal of Antimicrobial Chemotherapy|2020Cited by 16
Incidence and risk factors of AIDS-defining cancers in a cohort of HIV-positive adults: Importance of the definition of incident casesInés Suárez‐García, Inmaculada Jarrín, José Antonio Iribarren et al.|Enfermedades Infecciosas y Microbiología Clínica|2013Cited by 9
Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019–2021Laura Viñuela, Féderico García, Adolfo de Salazar et al.|Journal of Medical Virology|2023Cited by 7